← Eichor
Condition: Lichen Planus Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Lichen Planus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammato
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06599411
Determinants of Chronic Inflammatory Skin Disease Trajectories
Phase N/A · 1 location(s) · University Hospital Schleswig-Holstein · NCT05928169
Cellular and Molecular Biomarkers in Patients With Lichen Planus
NA · 6 location(s) · Institut Pasteur · NCT06451744
Nemolizumab to Treat Lichen Planopilaris, a Noncontrolled, Prospective, Pilot Study.
Phase 4 · 1 location(s) · The Skin Center Dermatology Group · NCT07396168
The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Lichen Planopilaris in Routine Clinical
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT06512753
Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic Therapy
NA · 1 location(s) · Peking University Third Hospital · NCT05973097
Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07487948
Observational Study of OROSEDAL in Sore Throat and Minor Oral Lesions
Phase N/A · 1 location(s) · Laboratoires Elerte · NCT07620353
The Efficacy of Tranexamic Acid in the Treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans
Phase 2 · 1 location(s) · Henry Ford Health System · NCT04233749
SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
Phase N/A · 1 location(s) · University of Palermo · NCT06321003
Photobiomodulation, Photodynamic Therapy, and Clobetasol in the Treatment of Oral Lichen Planus.
NA · 1 location(s) · Medical University of Silesia · NCT07278999
Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT03975322
Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD)
NA · 1 location(s) · Dalarna County Council, Sweden · NCT05296941
The Therapeutic Effect of Curcumin in Nanogels Compared to 0.1% FAO in the Management of Oral Lichen Planus
NA · 1 location(s) · Chulalongkorn University · NCT06932848
Evaluation of the Efficacy of 0.08% Tacrolimus Nanoencapsulated Aqueous Solution Spray Vs. 0.1% Free Tacrolimus Commerci
Phase 1/Phase 2 · 1 location(s) · Hospital de Clinicas de Porto Alegre · NCT06591884
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
NA · 14 location(s) · Stratpharma AG · NCT05953090
Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen Planus
Phase 2 · 1 location(s) · University of Palermo · NCT07100613
Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus
Phase 4 · 1 location(s) · All India Institute of Medical Sciences, Bhubaneswar · NCT07131813
Treatment Outcomes and Patient Satisfaction of Oral Lichen Planus Treatment
Phase 2/Phase 3 · 1 location(s) · Dar Al Uloom University · NCT06988527
Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus
Phase 2 · 1 location(s) · Cairo University · NCT06981767
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Phase 2/Phase 3 · 61 location(s) · Priovant Therapeutics, Inc. · NCT07532603
Rate of Malignant Transformation and Clinical Characteristics Among an Oral Lichen Planus Cohort: a Retrospective Center
Phase N/A · 1 location(s) · Catholic University of the Sacred Heart · NCT06934863
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.